Location: Home
  • search
  • go
  • Relate News
  • 10/15/2024BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
  • 10/15/2024Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
  • 10/15/2024China Solicits Comments on Draft Compliance Guidelines for Pharmaceuti...
  • 10/15/2024Review of Online Drug Sales Growth in China 2021-2023
  • 10/11/2024Chinese Health Insurance Premium Income Up 4.5% in 2023
  • 10/11/2024Recent Executive Moves
  • 10/10/2024QuantumPharma's Subsidiary Ailux Biologics Partners with Janssen Biote...
  • 10/10/2024Eli Lilly Submits Chinese NDA for Its Anti-IL23 Antibody Mirikizumab
  • 10/10/2024Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...
  • 10/10/2024Mainland China's Pharmaceutical Sales to Reach $345B by 2033: BMI/Fitc...
  • 10/9/2024US Venture Capital Opens Funding Opportunities for China Biotech Firms
  • 10/9/2024SMEI: Chinese Terminal Drug Market Grew 5.2% in 2023
  • 10/9/2024IQVIA Releases the 2024 White Paper on Development Trends in China's O...
  • 10/8/2024MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...
  • 10/8/2024Innovent and Ask Pharm Enter Strategic Deal for Limertinib 
  • 10/8/2024Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...
  • 10/8/2024Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor
  • 10/8/2024China to Establish a Unified Mapping Database for Traceability Codes, ...
  • 10/8/2024BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...
  • 10/8/2024CSPC Announces Regulatory Milestones in China and the U.S.
  • 10/8/2024NRDL China: 2024 Outlook (Simon Kucher)
  • 10/3/2024WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT
  • 10/3/2024Recent Executive Moves
  • 10/2/2024China Introduces Credit System for Hospital and Pharmacy Staff to Curb...
  • 10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Writing...
  • 10/2/2024Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
  • 10/1/2024HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...
  • 10/1/2024InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...
  • 10/1/2024Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...
  • 10/1/2024Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
  • Page:33/370 Total number of articles:11093: [First][<<] [31] [32] [33] [34] [35] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group